Onyx Therapeutics, Inc. is > 10% Shareholder of Kezar Life Sciences, Inc.. Currently has a direct ownership of 1.12 Million shares of KZR, which is worth approximately $616,761. The most recent transaction as insider was on Jun 25, 2018, when has been sold 1,121,384 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.12M
0% 3M change
0% 12M change
Total Value Held $616,761

Onyx Therapeutics, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2018
BUY
Conversion of derivative security
-
1,121,384 Added 50.0%
1,121,384 Common Stock
OTI

Onyx Therapeutics, Inc.

> 10% Shareholder
Thousand Oaks, CA

Track Institutional and Insider Activities on KZR

Follow Kezar Life Sciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KZR shares.

Notify only if

Insider Trading

Get notified when an Kezar Life Sciences, Inc. insider buys or sells KZR shares.

Notify only if

News

Receive news related to Kezar Life Sciences, Inc.

Track Activities on KZR